“In silico medicine” focuses on computational methods for the diagnosis, treatment or prevention of disease as well as the study of the human body functions in healthy subjects. More specifically, it refers to the modeling, simulation and visualization of biological, physiological and medical processes in a virtual environment. For twenty years it has gradually established itself as a third way alongside the in vitro and in vivo approaches. The research unit GIGA - In Silico Medicine consists of an interdisciplinary team of engineers, physicists, chemists and physicians who, by interacting with other thematic units of GIGA and clinicians, develop research activities along four main themes:
- Modeling of the cardiovascular and cardiopulmonary systems
- Tissue engineering
- Neuroimaging, data acquisition and processing
- Model-based therapeutics
As from this January, the GIGA's structure evolves. New teams are now included and there are now 8 thematic units: Cancer, Cardiovascular Sciences, Neurosciences, Immunity, Infection & Inflammation, Molecular Biology of Diseases, Medical Genomics, In Silico Medicine and CRC-In vivo Imaging. The direction of the GIGA-Research changes too, Michel Georges is taking over from Jacques Piette.